Last reviewed: June 11, 2026
Last updated: June 11, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Men exploring GLP-1 medications for weight management frequently raise concerns about potential effects on reproductive health and fertility. Research indicates that GLP-1 receptor agonists, including semaglutide, do not suppress testosterone production or damage sperm directly, making them a viable option for men seeking sustainable weight loss without sacrificing reproductive capacity.
How GLP-1 Medications Work in Male Bodies
GLP-1 receptor agonists activate receptors found throughout the digestive system and brain, signaling satiety and reducing appetite-driven eating. In men, these medications work through the same metabolic pathways as in women, slowing gastric emptying and enhancing insulin sensitivity. The medication does not interact directly with the hypothalamic-pituitary-gonadal axis, the hormone system responsible for testosterone production and sperm development.
Semaglutide and similar compounds concentrate in the gastrointestinal tract and central nervous system rather than accumulating in testicular tissue. This tissue-specific distribution means the drug avoids the reproductive organs at therapeutic doses, leaving testosterone synthesis and spermatogenesis intact. Men taking these medications maintain normal hormonal feedback loops unless significant underlying metabolic dysfunction exists.
Weight Loss, Testosterone, and Fertility Outcomes
Obesity itself impairs male fertility by elevating estrogen levels, reducing free testosterone, and decreasing sperm motility and morphology. When men achieve weight loss through GLP-1 therapy, they often experience improvement in testosterone concentrations and semen quality as metabolic health improves. A 2023 analysis in *Andrology* found that men losing 10% or more of body weight showed statistically significant increases in testosterone and improved sperm parameters within 6 to 12 months.
PlexusDx-guided semaglutide therapy starting at $149 per month enables sustained weight reduction that typically enhances rather than impairs male reproductive markers. The medication addresses the root metabolic problem—excess weight and insulin resistance—that was likely contributing to fertility challenges in the first place. As men lose weight, their hormonal environment becomes more favorable for sperm production and sexual function.
Potential Side Effects and Reproductive Concerns
Common GLP-1 side effects include nausea, constipation, and temporary appetite suppression, but none of these directly affect sperm production or erectile function. Some men report mild sexual side effects during the first 2 to 4 weeks of treatment as their bodies adjust, typically resolving as tolerance develops. Severe dehydration or rapid weight loss can theoretically impact sperm production in the short term, which is why controlled, medically supervised dosing matters.
PlexusDx compounded semaglutide from licensed 503A pharmacies includes medical support and dose titration designed to minimize acute side effects and allow the body time to adapt. Men should maintain consistent hydration, adequate micronutrient intake, and regular physical activity during treatment to support overall health and reproductive function. Any persistent changes in sexual performance or fertility concerns should be discussed with a healthcare provider overseeing GLP-1 therapy.
Precision Genetics and Personalized GLP-1 Response
Not all men respond identically to GLP-1 medications due to genetic variation in peptide signaling pathways. The PlexusDx Precision Peptide Genetic Test ($99 add-on after the first month) analyzes 14 metabolic pathways and 150+ genetic insights, including variants in GLP1R (rs6923761), GIPR (rs1800437), and MC4R (rs17782313) that influence medication effectiveness and side effect tolerance. Men with specific genetic predispositions may experience better weight loss, fewer gastrointestinal side effects, or improved hormonal outcomes on customized dosing.
Understanding a man's genetic profile helps PlexusDx-affiliated providers optimize dosing and compound selection—choosing between semaglutide injection ($149–$189/mo), oral semaglutide ($249/mo), tirzepatide ($249–$289/mo), or dual-compound GLP-Squared formulations. Personalized therapy reduces trial-and-error adjustments, lowers side effect burden, and maximizes the reproductive and metabolic benefits weight loss can provide. Men pursuing fertility goals alongside weight management benefit from this precision approach.
What the Clinical Evidence Says About GLP-1 and Male Reproduction
Multiple clinical trials and observational studies have examined GLP-1 receptor agonists in men with obesity and type 2 diabetes without identifying direct reproductive toxicity or impaired sperm production. The SUSTAIN trials and real-world data from endocrinology clinics consistently show stable or improved hormonal profiles in men using semaglutide long-term. No evidence currently suggests these medications reduce fertility potential in men with intact baseline reproductive function.
Men with pre-existing hypogonadism (low testosterone) or infertility should pursue formal fertility assessment and urologic evaluation before starting GLP-1 therapy, as underlying conditions—not the medication—would be the primary concern. For otherwise healthy men with obesity-related metabolic dysfunction, GLP-1 medications represent a low-risk, high-benefit option that may actually improve reproductive health through weight loss-driven hormonal restoration. PlexusDx supports men in making informed decisions by providing evidence-based guidance and precision-guided dosing.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Do GLP-1 medications like semaglutide harm sperm production?
No. GLP-1 receptor agonists do not directly target testicular tissue or suppress testosterone production. Clinical evidence from multiple trials shows no reproductive toxicity in men using semaglutide long-term. PlexusDx provides compounded semaglutide starting at $149/month with medical oversight to ensure safe, effective use.
Can weight loss from GLP-1 therapy improve male fertility?
Yes. Obesity impairs testosterone levels and sperm quality, so sustained weight loss through GLP-1 therapy often restores normal hormone profiles and improves semen parameters. Research shows men losing 10%+ of body weight experience measurable gains in testosterone and sperm motility within 6 to 12 months.
What is the price for semaglutide injection at PlexusDx?
PlexusDx compounded semaglutide injection starts at $149 per month across all commitment tiers. Your dose may need to go up. Your price won't. All medications are compounded by licensed 503A pharmacies, and treatment is available in all 50 states without insurance or membership fees.
Are there any side effects that could affect sexual function?
Most GLP-1 side effects (nausea, constipation) do not affect sexual performance or sperm production. Some men report temporary sexual side effects during the first few weeks as the body adjusts, which typically resolve. Maintaining hydration and micronutrient intake during treatment supports both overall health and reproductive function.
How can the PlexusDx Precision Peptide Genetic Test help me?
The $99 genetic test analyzes 150+ insights across peptide pathways including GLP1R, GIPR, MC4R, and FTO variants to personalize your GLP-1 dose and compound selection. Men with specific genetic profiles may experience better weight loss, fewer side effects, and improved hormonal outcomes, which can enhance fertility-related health benefits.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is There GLP-1 Pills? Exploring the Role of GLP-1 Agonists in Weight Loss and Diabetes Management
Will the Price of GLP-1 Go Down? Understanding the Future of Weight Loss Medications